Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 383 is a member of the KRAB-related zinc finger protein family and is encoded by the ZNF383 gene in humans. It is predicted to function as a transcriptional repressor, mainly inhibiting the transcription of genes that are part of the MAPK signaling pathway. The repressor activity is conferred by its KRAB domain, which is typical for a subset of zinc finger transcription factors. Its biological roles are closely linked to regulation of gene expression, particularly through DNA binding. Associations with disease are minimal, with some evidence pointing to a possible role in prostate carcinoma in situ, but ZNF383 is not currently considered a major therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 383 (ZNF383).